PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure

por Shah, T T, Peters, M, Kanthabalan, A, McCartan, N, Fatola, Y, van der Voort van Zyp, J, van Vulpen, M, Freeman, A, Moore, C M, Arya, M, Emberton, M, Ahmed, H U
Publicado 2016

ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement

por Green, S., Tuck, S., Long, J., Green, T., Green, A., Ellis, P., Haire, A., Moss, C., Cahill, F., McCartan, N., Brown, L., Santaolalla, A., Marsden, T., Justo, M. Rodriquez, Hadley, J., Punwani, S., Attard, G., Ahmed, H., Moore, C. M., Emberton, M., Van Hemelrijck, M.
Publicado 2021